LUNA vs. BASI, PGEN, MXCT, NOTV, ONMD, BIAF, AIKI, DKDCA, ISPC, and FOXO
Should you be buying Luna Innovations stock or one of its competitors? The main competitors of Luna Innovations include Bioanalytical Systems (BASI), Precigen (PGEN), MaxCyte (MXCT), Inotiv (NOTV), OneMedNet (ONMD), bioAffinity Technologies (BIAF), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), and FOXO Technologies (FOXO).
Luna Innovations (NASDAQ:LUNA) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and community ranking.
Luna Innovations has a net margin of -1.82% compared to Bioanalytical Systems' net margin of -7.75%. Luna Innovations' return on equity of 3.61% beat Bioanalytical Systems' return on equity.
Luna Innovations currently has a consensus price target of $10.00, suggesting a potential upside of 184.09%. Given Luna Innovations' higher possible upside, equities research analysts plainly believe Luna Innovations is more favorable than Bioanalytical Systems.
Luna Innovations has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500.
87.5% of Luna Innovations shares are owned by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are owned by institutional investors. 7.6% of Luna Innovations shares are owned by company insiders. Comparatively, 11.5% of Bioanalytical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Luna Innovations received 71 more outperform votes than Bioanalytical Systems when rated by MarketBeat users. Likewise, 61.23% of users gave Luna Innovations an outperform vote while only 41.16% of users gave Bioanalytical Systems an outperform vote.
In the previous week, Luna Innovations had 1 more articles in the media than Bioanalytical Systems. MarketBeat recorded 1 mentions for Luna Innovations and 0 mentions for Bioanalytical Systems. Luna Innovations' average media sentiment score of 0.00 equaled Bioanalytical Systems'average media sentiment score.
Luna Innovations has higher revenue and earnings than Bioanalytical Systems. Luna Innovations is trading at a lower price-to-earnings ratio than Bioanalytical Systems, indicating that it is currently the more affordable of the two stocks.
Summary
Luna Innovations beats Bioanalytical Systems on 13 of the 16 factors compared between the two stocks.
Get Luna Innovations News Delivered to You Automatically
Sign up to receive the latest news and ratings for LUNA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Luna Innovations Competitors List
Related Companies and Tools
